QUOIN PHARMACEUTICALS, INC.Side Letter Regarding Merger Agreement • September 17th, 2021 • Cellect Biotechnology Ltd. • Surgical & medical instruments & apparatus
Reference is hereby made to the Agreement and Plan of Merger and Reorganization, dated March 24, 2021 (the “Agreement”), by and among Cellect Biotechnology Ltd., an Israeli company (“Cellect”), CELLMSC, Inc., a Delaware corporation (“Merger Sub”), and Quoin Pharmaceuticals, Inc., a Delaware corporation (“Quoin”). Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.
